Answers are grounded in this paper and cite their sources.
In the BEST-CLI trial (Best Endovascular Versus Best Surgical Therapy for Patients With Chronic Limb-Threatening Ischemia), a prespecified secondary objective was to assess the effects of revascularization strategy on health-related quality of life (HRQoL).
No takes yet. Share an insight, caveat, or question.
Menard et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: